乐普生物-B拟配股总筹4.71亿港元 加速核心产品商业化及研发

格隆汇
Jul 04

格隆汇7月4日丨乐普生物-B(02157.HK)发布公告,2025年7月4日(于交易时段前),公司(作为发行人)与配售代理(即中信证券及汇丰)订立配售协议,据此,公司有条件同意发行,而配售代理有条件同意按单独(而非共同或共同及单独)基准,作为公司代理尽力促使以配售价每股H股5.02港元配售最多合共9382.5万股配售股份。配售股份(i)分别占公司于本公告日期全部现有已发行H股及全部现有已发行股本约...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10